Focus on endometrial and cervical cancer

Cancer Cell

Volumn 5, Issue 6, 2004, Pages 533-538

  Ellenson, Lora Hedrick ^a   Wu, T C ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS VACCINE; WART VIRUS VACCINE;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CELL CYCLE S PHASE; ENDOMETRIUM CANCER; GENE MUTATION; HUMAN; MISMATCH REPAIR; NONHUMAN; ONCOGENE; OVARY CANCER; PAPANICOLAOU TEST; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; WART VIRUS; WESTERN BLOTTING;

HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 2942578078     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.05.029     Document Type: Review

References (29)

1. Arbeit J.M., Howley P.M., Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;2930-2935
2. Bokhman J.V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 15:1983;10-17
3. Elson D.A., Riley R.R., Lacey A., Thordarson G., Talamantes F.J., Arbeit J.M. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res. 60:2000;1267-1275
4. Esteller M., Levine R., Baylin S.B., Ellenson L.H., Herman J.G. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene. 17:1998;2413-2417
5. Fahey M.T., Irwig L., Macaskill P. Meta-analysis of Pap test accuracy. Am. J. Epidemiol. 141:1995;680-689
6. Frazer I.H. Prevention of cervical cancer through papillomavirus vaccination. Nat. Rev. Immunol. 4:2004;46-54
7. Fukuchi T., Sakamoto M., Tsuda H., Maruyama K., Nozawa S., Hirohashi S. Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res. 58:1998;3526-3528
8. Gurin C.C., Federici M.G., Kang L., Boyd J. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res. 59:1999;462-466
9. Harro C.D., Pang Y.Y., Roden R.B., Hildesheim A., Wang Z., Reynolds M.J., Mast T.C., Robinson R., Murphy B.R., Karron R.A., et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 93:2001;284-292
10. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J. Clin. 52:2002;23-47
11. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., Chiacchierini L.M., Jansen K.U. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:2002;1645-1651
12. Kurman R.J., Kaminski P.F., Norris H.J. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 56:1985;403-412
13. Lambert P.F., Pan H., Pitot H.C., Liem A., Jackson M., Griep A.E. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA. 90:1993;5583-5587
14. Lax S.F., Kendall B., Tashiro H., Slebos R.J., Hedrick L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma. evidence of distinct molecular genetic pathways Cancer. 88:2000;814-824
15. Levine R.L., Cargile C.B., Blazes M.S., van Rees B., Kurman R.J., Ellenson L.H. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res. 58:1998;3254-3258
16. Maxwell G.L., Risinger J.I., Gumbs C., Shaw H., Bentley R.C., Barrett J.C., Berchuck A., Futreal P.A. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res. 58:1998;2500-2503
17. Monsonego J., Bosch F.X., Coursaget P., Cox J.T., Franco E., Frazer I., Sankaranarayanan R., Schiller J., Singer A., Wright T.C. Jr., et al. Cervical cancer control, priorities and new directions. Int. J. Cancer. 108:2004;329-333
18. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., Rotman M., Gershenson D.M., Mutch D.G. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340:1999;1137-1143
19. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P., Lees J.A., Weng L.P., Eng C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. 92:2000;924-930
20. Petry K.U., Menton S., Menton M., van Loenen-Frosch F., de Carvalho Gomes H., Holz B., Schopp B., Garbrecht-Buettner S., Davies P., Boehmer G., et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany. results for 8466 patients Br. J. Cancer. 88:2003;1570-1577
21. Roden R., Wu T.C. Preventative and therapeutic vaccines for cervical cancer. Expert Rev. Vaccines. 2:2003;495-516
22. Saegusa M., Hashimura M., Kuwata T., Hamano M., Okayasu I. beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of Cyclin D1 during Squamous differentiation of endometrial carcinoma cells. Am. J. Pathol. 164:2004;1739-1749
23. Sherman M.E., Lorincz A.T., Scott D.R., Wacholder S., Castle P.E., Glass A.G., Mielzynska-Lohnas I., Rush B.B., Schiffman M. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia. A 10-year cohort analysis J. Natl. Cancer Inst. 95:2003;46-52
24. Tashiro H., Blazes M.S., Wu R., Cho K.R., Bose S., Wang S.I., Li J., Parsons R., Ellenson L.H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecologic malignancies. Cancer Res. 57:1997;3935-3940. a
25. Tashiro H., Isacson C., Levine R., Kurman R.J., Cho K.R., Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur as an early event in their pathogenesis. Am. J. Pathol. 150:1997;177-185. b
26. Waggoner S.E. Cervical cancer. Lancet. 361:2003;2217-2225
27. Wang H., Douglas W., Lia M., Edelmann W., Kucherlapati R., Podsypanina K., Parsons R., Ellenson L.H. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Am. J. Pathol. 60:2002;1481-1486
28. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C. Jr., Clarke-Pearson D.L., Liao S.Y. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group study J. Clin. Oncol. 17:1999;1339-1348
29. zur Hausen H. Papillomaviruses and cancer. From basic studies to clinical application Nat. Rev. Cancer. 2:2002;342-350